BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38036693)

  • 1. Total hip replacement among sickle cell patients in a low-income country-Yemen.
    Mughalles AA; Alkholidy GG; AlSaifi MS; Al-Gabaly WM; Al-Haddad KM
    Int Orthop; 2024 Apr; 48(4):923-930. PubMed ID: 38036693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncemented Total Hip Arthroplasty in Sickle-Cell Disease: Long-Term Results.
    Ilyas I; Alrumaih HA; Rabbani S
    J Arthroplasty; 2018 Feb; 33(2):477-481. PubMed ID: 28993082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total hip arthroplasty survival in femoral head avascular necrosis versus primary hip osteoarthritis: Case-control study with a mean 10-year follow-up after anatomical cementless metal-on-metal 28-mm replacement.
    Ancelin D; Reina N; Cavaignac E; Delclaux S; Chiron P
    Orthop Traumatol Surg Res; 2016 Dec; 102(8):1029-1034. PubMed ID: 28341264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total hip replacement in sickle cell disorder: A preliminary report of challenges and early outcome of 21 consecutive patients.
    Katchy AU; Anyaehie UE; Nwadinigwe CU; Eyichukwu GO
    Niger J Clin Pract; 2018 Apr; 21(4):492-495. PubMed ID: 29607863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Minimum Ten Years of Follow-Up of Alumina Head on Delta Liner Total Hip Arthroplasty.
    Choy WS; Cha YH; Jeon CY; Lee KS; Kim HY
    J Arthroplasty; 2018 Feb; 33(2):470-476. PubMed ID: 28958658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of total hip arthroplasty (THA) in sickle cell disease.
    AlOmran AS
    Arch Orthop Trauma Surg; 2023 Dec; 143(12):7213-7218. PubMed ID: 37466724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Outcomes of Total Hip Arthroplasty between Patients with Ankylosing Spondylitis and Avascular Necrosis of the Femoral Head.
    Lee SH; Lee GW; Seol YJ; Park KS; Yoon TR
    Clin Orthop Surg; 2017 Sep; 9(3):263-269. PubMed ID: 28861192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total hip arthroplasty in sickle cell disease patients in a developing country.
    Ugbeye ME; Lawal W; Ayodabo O; Dim EM; Adegoke S
    Niger J Clin Pract; 2020 Oct; 23(10):1426-1430. PubMed ID: 33047701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceramic-on-ceramic cementless total hip arthroplasty in patients aged 40 years or under: Do preoperative conditions affect long-term results?
    Garcia-Rey E; Bizot P; Garcia-Cimbrelo E
    Orthop Traumatol Surg Res; 2021 Feb; 107(1):102763. PubMed ID: 33321234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short term results of cementless total hip arthroplasty in sicklers.
    Gulati Y; Sharma M; Bharti B; Bahl V; Bohra I; Goswani A
    Indian J Orthop; 2015; 49(4):447-51. PubMed ID: 26229167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cementless metaphyseal fitting anatomic total hip arthroplasty with a ceramic-on-ceramic bearing in patients thirty years of age or younger.
    Kim YH; Park JW; Kim JS
    J Bone Joint Surg Am; 2012 Sep; 94(17):1570-5. PubMed ID: 22992847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of Life in Sickle Cell Patients After Cementless Total Hip Arthroplasty.
    Azam MQ; Sadat-Ali M
    J Arthroplasty; 2016 Nov; 31(11):2536-2541. PubMed ID: 27240962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alumina Delta-on-Highly Crosslinked-Remelted Polyethylene Bearing in Cementless Total Hip Arthroplasty in Patients Younger than 50 Years.
    Kim YH; Park JW; Kim JS
    J Arthroplasty; 2016 Dec; 31(12):2800-2804. PubMed ID: 27378639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous bilateral total hip arthroplasty in sickle cell disease.
    Ilyas I; Moreau P
    J Arthroplasty; 2002 Jun; 17(4):441-5. PubMed ID: 12066273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total hip replacement in younger patients: survival rate after avascular necrosis of the femoral head.
    Schneider W; Knahr K
    Acta Orthop Scand; 2004 Apr; 75(2):142-6. PubMed ID: 15180228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mid-term functional and radiological outcomes after total hip replacement performed for complications of acetabular fractures.
    Salášek M; Pavelka T; Rezek J; Šídlo K; Šimánek M; Whitley A; Džupa V
    Injury; 2023 Aug; 54(8):110916. PubMed ID: 37394328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total Hip Arthroplasty After Acetabular Fracture Is Associated With Lower Survivorship and More Complications.
    Morison Z; Moojen DJ; Nauth A; Hall J; McKee MD; Waddell JP; Schemitsch EH
    Clin Orthop Relat Res; 2016 Feb; 474(2):392-8. PubMed ID: 26335343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total hip replacement in sickle cell disease.
    Al-Mousawi F; Malki A; Al-Aradi A; Al-Bagali M; Al-Sadadi A; Booz MM
    Int Orthop; 2002; 26(3):157-61. PubMed ID: 12073108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of 200 Consecutive Ceramic-on-Ceramic Cementless Hip Arthroplasties in Patients Up To 50 Years of Age: A 5-24 Years of Follow-Up Study.
    Solarino G; Zagra L; Piazzolla A; Morizio A; Vicenti G; Moretti B
    J Arthroplasty; 2019 Jul; 34(7S):S232-S237. PubMed ID: 30777621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total hip arthroplasty with cementless cups and femoral head autografts for patients with hip dysplasia and osteoarthritis.
    Wu LD; Jin LB; Yan SG; Yang QS; Dai XS; Wang XH
    Chin J Traumatol; 2004 Oct; 7(5):280-5. PubMed ID: 15363221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.